172 Body mass index (BMI) and serum albumin level as a predictor of survival outcomes in advanced-stage melanoma patients treated with anti-PD1 therapy | Zendy

AI Assistant Blog Pricing

172 Body mass index (BMI) and serum albumin level as a predictor of survival outcomes in advanced-stage melanoma patients treated with anti-PD1 therapy

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.